PONTE VEDRA, Fla., Dec. 11, 2025 -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome the limitations of current anticoagulation therapy, today announced the acquisition...
Barry Myers will be speaking on a panel discussing financing mechanisms for emerging companies at the Life Sciences Summit 2011 in New York on November 16.
News | 11. 11. 2011
